Concepedia

Chaoqiang An

CA

Statistics

Publications

11

Citations

587

H-Index

10

Active since

2012

Affiliations

National Institutes for Food and Drug Control(Current)

University of Chinese Academy of Sciences

Beijing Institute of Genomics

Changchun Institute of Biological Products

National Medical Products Administration

Chaoqiang An is an author at National Institutes for Food and Drug Control specializing in life sciences, vaccinology, and immunology.

ORCID

Publications per year

2012–2023

11

Publications

11

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Qian He, Qunying Mao, Chaoqiang An et al. · Emerging Microbes & Infections · 2021 · 168 citations · Full text

, , +17

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Qian He, Chaoqiang An, Qunying Mao et al. · Emerging Microbes & Infections · 2021 · 104 citations · Full text

, , +17

TMCO1 is essential for ovarian follicle development by regulating ER Ca2+ store of granulosa cells

Zhongshuai Sun, Hui Zhang, Xi Wang et al. · Cell Death and Differentiation · 2018 · 95 citations · Full text

, , +17

Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway

Yun Jiang, Linfang Lu, Youtao Hu et al. · Scientific Reports · 2016 · 65 citations · Full text

, , +11

Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway

Lei Zhou, Xiaolan Yu, Qingjie Meng et al. · Hepatology · 2012 · 53 citations

, , +17

1–5 of 11